Scientific publications 2002

1. Bessis, N., Doucet, C., Cottard, V., Douar, A.M., Firat, H., Jorgensen, C., Mezzina, M. and Boissier, M.C.: “Gene therapy for rheumatoid arthritis”. J Gene Med 4 (2002) 581-91.

2. Chantret, I., Dupre, T., Delenda, C., Bucher, S., Dancourt, J., Barnier, A., Charollais, A., Heron, D., Bader-Meunier, B., Danos, O., Seta, N., Durand, G., Oriol, R., Codogno, P. and Moore, S.E.: “Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase”. J Biol Chem 277 (2002) 25815-25822.

3. De Lonlay, P., Mugnier, C., Sanlaville, D., Chantrel-Groussard, K., Benit, P., Lebon, S., Chretien, D., Kadhom, N., Saker, S., Gyapay, G., Romana, S., Weissenbach, J., Munnich, A., Rustin, P. and Rotig, A.: “Cell complementation using Genebridge 4 human:rodent hybrids for physical mapping of novel mitochondrial respiratory chain deficiency genes”. Hum Mol Genet 11 (2002) 3273-81.

4. De Sandre-Giovannoli, A., Chaouch, M., Kozlov, S., Vallat, J.M., Tazir, M., Kassouri, N., Szepetowski, P., Hammadouche, T., Vandenberghe, A., Stewart, C.L., Grid, D. and Levy, N.: “Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse”. Am J Hum Genet 70 (2002) 726-736 (Erratum in: Am J Hum Genet 2002 Apr;70(4):1075.

5. Delenda, C., Audit, M. and Danos, O.: “Biosafety issues in lentivector production”. In: Trono, D. (Ed.), Lentiviral Vectors. Springer-Verlag, Berlin, 2002, pp. 123-141.

6. Duan, M.L., Bordet, T., Mezzina, M., Kahn, A. and Ulfendahl, M.: “Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea”. Neuroreport 13 (2002) 1295-1299.

7. Durand, M., Suel, L., Barbet, J.P., Beckmann, J.S. and Fougerousse, F.: “Sequential expression of genes involved in muscular dystrophies during human development”. Morphologie 86 (2002) 9-12.

8. Feasson, L., Stockholm, D., Freyssenet, D., Richard, I., Duguez, S., Beckmann, J.S. and Denis, C.: “Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle”. J Physiol 543 (2002) 297-306.

9. Firat, H., Cochet, M., Rohrlich, P.S., Garcia-Pons, F., Darche, S., Danos, O., Lemonnier, F.A. and Langlade-Demoyen, P.: “Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice”. Int Immunol 14 (2002) 925-934.

10. Firat, H., Zennou, V., Garcia-Pons, F., Ginhoux, F., Cochet, M., Danos, O., Lemonnier, A.F., Langlade-Demoyen, P. and Charneau, P.:“Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy”. J Gene Med 4 (2002) 38-45.

11. Fougerousse, F., Durand, M., Lopez, S., Suel, L., Demignon, J., Thornton, C., Ozaki, H., Kawakami, K., Barbet, P., Beckmann, J.S. and Maire, P.: “Six and Eya expression during human somitogenesis and MyoD gene family activation”. J Muscle Res Cell Motil 23 (2002) 255-264.

12. Genin, E., Huebner, A., Jaillard, C., Faure, A., Halaby, G., Saka, N., Clark, A.J.L., Durand, P., Begeot, M. and Naville, D.: “Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity”. Human Genetics 111 (2002) 428-434.

13. Hackman, P., Vihola, A., Haravuori, H., Marchand, S., Sarparanta, J., De Seze, J., Labeit, S., Witt, C., Peltonen, L., Richard, I. and Udd, B.:“Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin”. Am J Hum Genet 71 (2002) 492-500.

14. Hamel, Y., Blake, N., Gabrielsson, S., Haigh, T., Jooss, K., Martinache, C., Caillat-Zucman, S., Rickinson, A.B., Hacein-Bey, S., Fischer, A. and Cavazzana-Calvo, M.: “Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy”. Hum Gene Ther 13 (2002) 855-866.

15. Hernandez, J., Garcia-Pons, F., Lone, Y.C., Firat, H., Schmidt, J.D., Langlade-Demoyen, P. and Zanetti, M.: “Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells”. Proc Natl Acad Sci USA 99 (2002) 12275-12280.

16. Jobard, F., Lefèvre, C., Karaduman, A., Blanchet-Bardon, C., Emre, S., Weissenbach, J., Özgüc, M., Lathrop, M., Prud’homme, J.F. and Fischer, J.: “Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1”. Hum Mol Genet 11 (2002) 107-113.

17. Kichler, A., Chillon, M., Leborgne, C., Danos, O. and Frisch, B.: “Intranasal gene delivery with a polyethylenimine-PEG conjugate”. J Control Release 81 (2002) 379-388.

18. Kissa, K., Mordelet, E., Soudais, C., Kremer, E., Demeneix, B., Brulet, P. and Coen, L.: “In vivo neuronal tracing with GFP-TTC gene delivery”. Mol Cell Neurosci 20 (2002) 627-637.

19. Lambolez, F., Jooss, K., Vasseur, F. and Sarukhan, A.: “Tolerance induction to self antigens by peripheral dendritic cells”. Eur J Immunol 32 (2002) 2588-2597.

20. Li Duan, M., Bordet, T., Mezzina, M., Kahn, A. and Ulfendahl, M.: “Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea”. Neuroreport 13 (2002) 1295-1299.

21. Mahe, E., Lahfa, M., Mansouri, S., Mosharraf-Olmolk, H., Le Rebours, J., Prud’homme, J.F. and Fischer, J.: “Physicians’ response to a letter to confirm diagnosis in a genetic study of psoriasis”. Eur J Dermatol 12 (2002) 66-69.

22. Martin-Touaux, E., Puech, J.P., Chateau, D., Emiliani, C., Kremer, E.J., Raben, N., Tancini, B., Orlacchio, A., Kahn, A. and Poenaru, L.:“Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy”. Hum Mol Genet 11 (2002) 1637-1645.

23. Mathews, L.C., Gray, J.T., Gallagher, M.R. and Snyder, R.O.: “Recombinant adeno-associated viral vector production using stable packaging and producer cell lines”. In: Phillips, I. (Ed.), Gene Therapy Methods. Academic Press, San Diego, 2002, pp. 393-413.

24. Merten, O.-W.: “Development of serum-free media for cell growth and production of viruses / viral vaccines – safety issues of animal products used in serum-free media”. In: Brown, F., Hendriksen, C., Sesardic, D. and Cussler, K. (Eds.), Advancing Science and Elimination of the Use of Laboratory Animals for Development and Control of Vaccines and Hormones – Symposium, Utrecht, November 2001: Proceedings. S. Karger AG, Basel, 2002, pp. 233-257.

25. Merten, O.-W.: “Virus contaminations of cell cultures – A biotechnological view”. Cytotech 39 (2002) 91-116.

26. Mezzina, M.: “First meeting of the Gene Vector Production network, 4-5 October 2001, Evry, France”. J Gene Med 4 (2002) 105-108.

27. Mezzina, M. and Danos, O.: “Five years of vector service for gene therapy”. Trends Genet 18 (2002) 118-119.

28. Morante-Redolat, J.M., Gorostidi-Pagola, A., Piquer-Sirerol, S., Saenz, A., Poza, J.J., Galan, J., Gesk, S., Sarafidou, T., Mautner, V.F., Binelli, S., Staub, E., Hinzmann, B., French, L., Prud’homme, J.F., Passarelli, D., Scannapieco, P., Tassinari, C.A., Avanzini, G., Marti-Masso, J.F., Kluwe, L., Deloukas, P., Moschonas, N.K., Michelucci, R., Siebert, R., Nobile, C., Perez-Tur, J. and Lopez de Munain, A.: “Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy”. Hum Mol Genet 11 (2002) 1119-1128.

29. Moulard, B., Genton, P., Grid, D., Jeanpierre, M., Ouazzani, R., Mrabet, A., Morris, M., LeGuern, E., Dravet, C., Mauguiere, F., Utermann, B., Baldy-Moulinier, M., Belaidi, H., Bertran, F., Biraben, A., Ali Cherif, A., Chkili, T., Crespel, A., Darcel, F., Dulac, O., Geny, C., Humbert-Claude, V., Kassiotis, P., Buresi, C. and Malafosse, A.: “Haplotype study of West European and North African Unverricht-Lundborg chromosomes: evidence for a few founder mutations”. Hum Genet 111 (2002) 255-62.

30. Nabbout, R., Prud’homme, J.F., Herman, A., Feingold, J., Brice, A., Dulac, O. and LeGuern, E.: “A locus for simple pure febrile seizures maps to chromosome 6q22-q24”. Brain 125 (2002) 2668-80.

31. Peltékian, E., Garcia, L. and Danos, O.: “Neurotropism and retrograde axonal transport of a canine adenoviral vector: A tool for targeting key structures undergoing neurodegenerative processes”. Mol Ther 5 (2002) 25-32.

32. Perez, N., Plence, P., Millet, V., Greuet, D., Minot, C., Noel, D., Danos, O., Jorgensen, C. and Apparailly, F.: “Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis”. Hum Gene Ther 13 (2002) 2161-72.

33. Robertson, A., Perea, J., Tolmachova, T., Thomas, P.K. and Huxley, C.: “Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice”. Gene 282 (2002) 65-74.

34. Sander, T., Windemuth, C., Schulz, H., Saar, K., Gennaro, E., Bianchi, A., Zara, F., Bulteau, C., Kaminska, A., Ville, D., Cieuta, C., Prud’homme, J.F., Dulac, O., Bate, L., Gardiner, R.M., de Haan, G.J., Janssen, G.A., Witte, J., Halley, D.J., Lindhout, D., Wienker, T.F. and Janz, D.: “No evidence for a susceptibility locus for idiopathic generalized epilepsy on chromosome 18q21.1”. Am J Med Genet 114 (2002) 673-8.

35. Schneider, H., Muhle, C., Douar, A.M., Waddington, S., Jiang, Q.J., Von der Mark, K., Coutelle, C. and Rascher, W.: “Sustained delivery of therapeutic concentrations of human clotting factor IX – a comparison of adenoviral and AAV vectors administered in utero”. J Gene Med 4 (2002) 46-53.

36. Spencer, M.J., Guyon, J.R., Sorimachi, H., Potts, A., Richard, I., Herasse, M., Chamberlain, J., Dalkilic, I., Kunkel, L.M. and Beckmann, J.S.: “Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation”. Proc Natl Acad Sci USA 99 (2002) 8874-8879.

37. Taveau, M., Stockholm, D., Spencer, M. and Richard, I.: “Quantification of splice variants using molecular beacon or scorpion primers”. Anal Biochem 305 (2002) 227-235.

38. Tazir, M., Vallat, J.M., Bomont, P., Zemmouri, R., Sindou, P., Assami, S., Nouioua, S., Hammadouche, T., Grid, D. and Koenig, M.:“Genetic heterogeneity in giant axonal neuropathy: an Algerian family not linked to chromosome 16q24.1”. Neuromuscul Disord 12 (2002) 849-52.

39. Viollet, L., Barois, A., Rebeiz, J.G., Rifai, Z., Burlet, P., Zarhrate, M., Vial, E., Dessainte, M., Estournet, B., Kleinknecht, B., Pearn, J., Adams, R.D., Urtizberea, J.A., Cros, D.P., Bushby, K., Munnich, A. and Lefebvre, S.: “Mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13”. Ann Neurol 51 (2002) 585-592.

40. Wesa, A. and Galy, A.: “Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand”. BMC Immunol 3 (2002) 14.

41. Windemuth, C., Schulz, H., Saar, K., Gennaro, E., Bianchi, A., Zara, F., Bulteau, C., Kaminska, A., Ville, D., Cieuta, C., Nabbout-Tarantino, R., Prud’homme, J.F., Dulac, O., Bate, L., Gardiner, R., Lindhout, D., Wienker, T., Janz, D. and Sander, T.: “No evidence for a susceptibility locus for idiopathic generalized epilepsy on chromosome 5 in families with typical absence seizures”. Epilepsy Res 51 (2002) 23-9.

42. Yates, F., Malassis-Seris, M., Stockholm, D., Bouneaud, C., Larousserie, F., Noguiez-Hellin, P., Danos, O., Kohn, D.B., Fischer, A., De Villartay, J.P. and Cavazzana-Calvo, M.: “Gene therapy of RAG-2-/-mice: sustained correction of the immunodeficiency”. Blood 100 (2002) 3942-3949.